CSafe launches transport packaging for gene therapy market

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story

Related Topics

Latest pharma logistics news

Challenge Group launches freighter service to Mumbai

Challenge Group has decided to launch a scheduled freighter route between Mumbai (BOM) and Liège (LGG). Operating twice weekly, the…

Read More

Share this story

Puerto Rico’s ETH Cargo achieves CEIV Pharma

Puerto Rico-based logistics firm ETH Cargo Services has achieved IATA CEIV Pharma certification ahead of an airport community drive to…

Read More

Share this story

Pharma.Aero launches sustainability index

Supply chain organisation Pharma.Aero has developed a new sustainability index to help air cargo companies involved in the transport of…

Read More

Share this story

Damian Brett

Damian Brett
I have been writing about the freight and logistics industry since 2007 when I joined International Freighting Weekly to cover the shipping sector.After a stint in PR, I have gone on to work for Containerisation International and Lloyds List - where I was editor of container shipping - before joining Air Cargo News in 2015.Contact me on [email protected]